BioWorld - Friday, March 28, 2025 Breaking News: BioWorld by Clarivate releases comprehensive 2024 year in review See today's BioWorld Science Home » Smsbiotech’s small mobile stem cell therapy ...
The UK's first stem cell collection centre strictly dedicated to transplants has started welcoming donors. The Anthony Nolan ...
Smsbiotech Inc. has gained clearance in Australia to begin a phase I trial of its small mobile stem (SMS) cell therapy for chronic obstructive pulmonary disease (COPD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback